Healthcare - Biotechnology - NASDAQ - US
$ 18.31
-5.86 %
$ 13.5 B
Market Cap
-79.61
P/E
INCOME STATEMENT
0
REVENUE
-89.7 M
OPERATING INCOME
-615 M
NET INCOME
EFFICIENCY
Earnings Waterfall
Summit Therapeutics Inc.
| Revenue | 0 |
| Cost Of Revenue | 2.05 M |
| Gross Profit | -2.05 M |
| Operating Expenses | 87.7 M |
| Operating Income | -89.7 M |
| Other Expenses | 525 M |
| Net Income | -615 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Jan-2019 | Jan-2018 | Jan-2017 | Jan-2016 | Jan-2015 | Jan-2014 | Jan-2013 | Jan-2012 | Jan-2011 | Jan-2010 | Jan-2009 | Jan-2008 | Jan-2007 | Jan-2006 | Jan-2005 | Jan-2004 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| REVENUE | |||||||||||||||||||||
| Revenue | 0 | 0.7 | 1.8 | 0.9 | 0.8 | 56.4 | 36.0 | 2.9 | 0 | 2.3 | 2.3 | 2.9 | 2.8 | 1.2 | 0.3 | 0.3 | 6.0 | 2.0 | 0.9 | 0.2 | 1.82 K |
| GROSS PROFIT | |||||||||||||||||||||
| Cost Of Revenue | 2.0 | 2.5 | 0 | 0 | 0.2 | 24.9 K | 97.7 K | 0 | 0 | 0 | 0 | 0 | 1.0 | 0 | 0 | 5.77 K | 2.5 | 0.6 | 0.4 | 0.2 | 1.82 K |
| Gross Profit | (2.0) | (1.8) | 1.8 | 0.9 | 0.6 | 56.4 | 35.9 | 2.9 | 0 | 2.3 | 2.3 | 2.9 | 1.8 | 1.2 | 0.3 | 0.3 | 3.5 | 1.4 | 0.5 | 43.3 K | 0 |
| OPERATING INCOME | |||||||||||||||||||||
| Operating Expenses | 87.7 | 64.3 | 88.0 | 53.2 | 53.9 | 47.7 | 54.1 | 33.9 | 29.4 | 19.3 | 13.3 | 8.5 | 7.5 | 5.6 | 9.5 | 15.4 | 26.9 | 10.0 | 3.7 | 0.6 | 43.8 K |
| Selling, General and Administrative Expenses | 28.2 | 26.7 | 23.6 | 19.2 | 11.9 | 16.2 | 17.0 | 10.3 | 7.5 | 6.8 | 3.2 | 2.8 | 2.3 | 2.7 | 4.2 | 5.0 | 7.3 | 1.9 | 1.8 | 75.3 K | 43.8 K |
| Research and Development Expenses | 59.5 | 52.0 | 85.4 | 53.3 | 42.0 | 51.4 | 41.0 | 23.7 | 23.9 | 15.6 | 10.8 | 5.7 | 4.8 | 3.7 | 3.7 | 7.4 | 15.3 | 5.8 | 1.8 | 0.5 | 0 |
| Operating Income | (89.7) | (72.1) | (86.2) | (53.2) | (54.9) | 12.4 | (18.3) | (31.1) | (28.7) | (19.2) | (11.1) | (7.2) | (4.7) | (9.4) | (9.2) | (19.2) | (23.4) | (8.6) | (3.2) | (0.5) | 43.8 K |
| PRE-TAX INCOME | |||||||||||||||||||||
| Interest Income Expense | 16.5 | 4.4 | 0.3 | 0.3 | 41.8 K | 0.6 | 1.6 | 1.1 | (0.4) | 14.8 K | 0 | 0 | 4.71 K | 6.33 K | 0.1 | 0.1 | 75.6 K | 11.8 K | 0 | 0 | 0 |
| Total Other Income | (526.1) | (19.1) | (24.9) | (14.0) | (1.3) | (3.3) | 1.9 | (0.9) | 5.5 | (0.4) | 14.8 K | 17.4 K | 6.28 K | 20.6 K | 94.3 K | 0.3 | 1.5 | 1.7 | 1.0 | 0.4 | 1.82 K |
| Pre-Tax Income | (615.9) | (78.8) | (88.6) | (52.9) | (36.5) | 6.6 | (15.4) | (32.1) | (28.7) | (19.1) | (11.1) | (7.2) | (4.7) | (9.4) | (9.3) | (18.9) | (21.9) | (6.9) | (2.2) | (0.1) | 42 K |
| NET INCOME | |||||||||||||||||||||
| Tax Provision | (0.9) | (4.4) | (2.5) | (0.2) | (5.8) | (3.3) | (5.3) | (5.4) | (4.4) | (2.0) | (1.0) | (0.5) | (0.5) | (1.9) | (0.6) | (2.5) | (1.8) | (1.0) | (0.3) | 45.2 K | 1.82 K |
| Net Income | (614.9) | (74.4) | (86.1) | (52.7) | (30.7) | 9.9 | (10.1) | (26.7) | (24.3) | (17.1) | (10.1) | (6.7) | (4.2) | (7.4) | (8.7) | (32.3) | (20.1) | (5.9) | (1.9) | 86.6 K | 42 K |
| EPS | 0.99 | 0.38 | 0.93 | 0.76 | 0.19 | 0.11 | 0.16 | 0.43 | 0.41 | 0.43 | 2.08 | 0.42 | 0.0238 | 0.0446 | 0.13 | 0.6 | 0.42 | 0.16 | 0.0605 | 0.0037 | 0.0022 |